Definition
The Food and Drug Administration (FDA) is a Partner Government Agency (PGA) essential for regulating various products—including biological products, medical devices, food, and cosmetics—to ensure their safety, security, and efficacy for the US public. The FDA holds imported products to the exact same rigorous standards as domestically produced goods under the Federal Food, Drug and Cosmetic Act.
Compliance and Enforcement
All imported FDA-regulated goods undergo review for compliance. If a shipment fails to meet standards or requires further examination, the FDA may issue an FDA hold. This is a type of customs hold placed after initial review.
Once a hold is placed, the agency may:
• Review and release the shipment.
• Request additional documentation or information.
• Inspect the cargo physically.
• Detain the goods if they fail to meet appropriate standards, potentially refusing entry.
Regulated Product Categories
Importers must be aware that the FDA regulates a wide range of products, including:
• Human foods
• Human drugs
• Vaccines, blood, and biologics
• Medical devices
• Radiation-emitting electronic products (e.g. LED lights)
• Cosmetics
• Animal and veterinary products
• Tobacco products
Expert Compliance Advice
Due to the complexity and strict requirements associated with FDA import clearance, most importers hire experienced customs brokers. A skilled broker assists with pre-filing requirements, documentation management, and expediting the release process, significantly minimizing the risk of costly FDA holds and detentions.
-
Navigating Enhanced European EPR Compliance: A Strategic Imperative for Cross-Border Sellers in 2026
The year 2026 marks a critical juncture for cross-border sellers in Europe as Extended Producer Responsibility (EPR) requirements for packaging, electronics, and textiles are comprehensively strengthened. This regulatory evolution presents significant challenges, including complex registration processes, escalating compliance costs, and stringent enforcement by platforms like Amazon.
2026-03-04
-
Tariff Creep: Deconstructing the Margin Compression Impact on Global Supply Chains
The "Tariff Creep" phenomenon, characterized by the gradual integration of new tariff costs into consumer pricing, is actively compressing profit margins across the supply chain. As pre-tariff inventory depletes, businesses face critical decisions regarding price adjustments versus sales velocity. LMLC analyzes the mechanisms and strategic implications for sustained market competitiveness.
2026-03-03